Recent data released by federal health officials has revealed a surprising improvement in the number of new hepatitis C infections in the United States in 2022. After more than a decade of steady increases, there was a 6% decline in new infections, sparking cautious optimism among experts.
While it remains uncertain whether this decrease is a temporary fluctuation or the beginning of a positive trend, public health officials are eagerly awaiting the release of 2023 and 2024 data to gain a clearer understanding of the situation.
